BerandaPTCT • NASDAQ
add
PTC Therapeutics, Inc.
$61,09
Setelah Jam Perdagangan Normal:(0,00%)0,00
$61,09
Tutup: 12 Sep, 16.32.03 GMT-4 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$60,96
Rentang hari
$60,48 - $62,18
Rentang tahun
$33,19 - $62,18
Kapitalisasi pasar
4,85Â M USD
Volume Rata-Rata
1,36Â jt
Rasio P/E
8,77
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 178,88Â jt | -4,19% |
Biaya operasional | 89,32Â jt | 23,43% |
Laba bersih | -64,85Â jt | 34,61% |
Margin laba bersih | -36,25 | 31,76% |
Penghasilan per saham | -0,83 | 34,63% |
EBITDA | -27,28Â jt | -3,55% |
Tarif pajak efektif | 8,73% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 2,00Â M | 82,92% |
Total aset | 2,63Â M | 37,46% |
Total liabilitas | 2,84Â M | -1,93% |
Total ekuitas | -206,55 jt | — |
Saham yang beredar | 79,44 jt | — |
Harga terhadap nilai buku | -23,45 | — |
Tingkat pengembalian aset | -3,29% | — |
Tingkat pengembalian modal | -3,81% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -64,85Â jt | 34,61% |
Kas dari operasi | -58,33Â jt | 18,36% |
Kas dari investasi | -422,01Â jt | -540,15% |
Kas dari pembiayaan | 3,96Â jt | -98,39% |
Perubahan kas bersih | -462,79Â jt | -545,34% |
Arus kas bebas | -7,84Â jt | -1.865,45% |
Tentang
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases.
In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019. Wikipedia
Didirikan
1 Jan 1998
Kantor pusat
Situs
Karyawan
939
